Diamond Hill Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $172M | Sell |
6,108,570
-3,330,697
| -35% | -$88.7M | 1.07% | 34 |
|
|
2025
Q4 | $235M | Sell |
9,439,267
-1,485,000
| -14% | -$37.4M | 1.2% | 31 |
|
|
2025
Q3 | $278M | Sell |
10,924,267
-6,740,086
| -38% | -$166M | 1.32% | 32 |
|
|
2025
Q2 | $428M | Sell |
17,664,353
-952,171
| -5% | -$22.2M | 1.97% | 16 |
|
|
2025
Q1 | $472M | Sell |
18,616,524
-6,832
| -0% | -$179K | 2.16% | 12 |
|
|
2024
Q4 | $494M | Buy |
18,623,356
+2,069,359
| +13% | +$56.1M | 2.18% | 11 |
|
|
2024
Q3 | $479M | Buy |
16,553,997
+658,420
| +4% | +$19.2M | 1.94% | 16 |
|
|
2024
Q2 | $445M | Sell |
15,895,577
-210,435
| -1% | -$5.79M | 1.9% | 15 |
|
|
2024
Q1 | $447M | Buy |
16,106,012
+4,307,439
| +37% | +$120M | 1.82% | 18 |
|
|
2023
Q4 | $340M | Buy |
11,798,573
+5,194,844
| +79% | +$157M | 1.49% | 26 |
|
|
2023
Q3 | $219M | Sell |
6,603,729
-296,444
| -4% | -$10.5M | 1.06% | 40 |
|
|
2023
Q2 | $253M | Buy |
6,900,173
+131,305
| +2% | +$5.11M | 1.14% | 36 |
|
|
2023
Q1 | $276M | Sell |
6,768,868
-30,443
| -0.4% | -$1.31M | 1.29% | 33 |
|
|
2022
Q4 | $348M | Sell |
6,799,311
-1,196,478
| -15% | -$57.4M | 1.58% | 20 |
|
|
2022
Q3 | $350M | Sell |
7,995,789
-1,117,441
| -12% | -$54.3M | 1.68% | 19 |
|
|
2022
Q2 | $478M | Sell |
9,113,230
-293,502
| -3% | -$15M | 2.09% | 11 |
|
|
2022
Q1 | $487M | Sell |
9,406,732
-413,679
| -4% | -$21.5M | 1.81% | 16 |
|
|
2021
Q4 | $580M | Sell |
9,820,411
-825,746
| -8% | -$40.9M | 2.07% | 13 |
|
|
2021
Q3 | $458M | Sell |
10,646,157
-1,035,221
| -9% | -$45.9M | 1.74% | 21 |
|
|
2021
Q2 | $457M | Buy |
11,681,378
+438,427
| +4% | +$17M | 1.74% | 19 |
|
|
2021
Q1 | $407M | Buy |
11,242,951
+2,064,225
| +22% | +$73.3M | 1.65% | 22 |
|
|
2020
Q4 | $338M | Sell |
9,178,726
-3,045
| -0% | -$112K | 1.59% | 22 |
|
|
2020
Q3 | $320M | Sell |
9,181,771
-93,170
| -1% | -$3.27M | 1.76% | 17 |
|
|
2020
Q2 | $288M | Buy |
9,274,941
+66,637
| +0.7% | +$2.26M | 1.7% | 19 |
|
|
2020
Q1 | $285M | Buy |
9,208,304
+638,789
| +7% | +$21.8M | 1.93% | 12 |
|
|
2019
Q4 | $319M | Sell |
8,569,515
-124,617
| -1% | -$4.44M | 1.6% | 17 |
|
|
2019
Q3 | $296M | Buy |
8,694,132
+576,054
| +7% | +$20.9M | 1.58% | 19 |
|
|
2019
Q2 | $334M | Buy |
8,118,078
+120,224
| +2% | +$4.77M | 1.78% | 16 |
|
|
2019
Q1 | $322M | Buy |
7,997,854
+300,056
| +4% | +$12M | 1.77% | 16 |
|
|
2018
Q4 | $319M | Sell |
7,697,798
-785,843
| -9% | -$32.6M | 1.87% | 14 |
|
|
2018
Q3 | $355M | Sell |
8,483,641
-534,421
| -6% | -$20.6M | 1.77% | 17 |
|
|
2018
Q2 | $310M | Sell |
9,018,062
-1,002,916
| -10% | -$34.3M | 1.59% | 21 |
|
|
2018
Q1 | $337M | Sell |
10,020,978
-1,477,217
| -13% | -$50.8M | 1.73% | 18 |
|
|
2017
Q4 | $395M | Sell |
11,498,195
-231,345
| -2% | -$7.89M | 1.98% | 12 |
|
|
2017
Q3 | $397M | Sell |
11,729,540
-214,096
| -2% | -$6.88M | 2.09% | 10 |
|
|
2017
Q2 | $381M | Sell |
11,943,636
-1,081,768
| -8% | -$34.1M | 2.05% | 8 |
|
|
2017
Q1 | $423M | Sell |
13,025,404
-631,302
| -5% | -$19.9M | 2.37% | 4 |
|
|
2016
Q4 | $421M | Buy |
13,656,706
+1,160,205
| +9% | +$35.4M | 2.44% | 4 |
|
|
2016
Q3 | $402M | Buy |
12,496,501
+221,028
| +2% | +$7.39M | 2.48% | 4 |
|
|
2016
Q2 | $410M | Buy |
12,275,473
+422,620
| +4% | +$13.5M | 2.59% | 4 |
|
|
2016
Q1 | $333M | Buy |
11,852,853
+552,539
| +5% | +$15.8M | 2.12% | 13 |
|
|
2015
Q4 | $346M | Buy |
11,300,314
+358,822
| +3% | +$11.3M | 2.3% | 5 |
|
|
2015
Q3 | $326M | Buy |
10,941,492
+153,888
| +1% | +$4.93M | 2.25% | 7 |
|
|
2015
Q2 | $343M | Sell |
10,787,604
-208,094
| -2% | -$6.78M | 2.28% | 8 |
|
|
2015
Q1 | $363M | Sell |
10,995,698
-190,283
| -2% | -$6.05M | 2.52% | 6 |
|
|
2014
Q4 | $331M | Buy |
11,185,981
+439,643
| +4% | +$12.6M | 2.36% | 6 |
|
|
2014
Q3 | $301M | Buy |
10,746,338
+861,070
| +9% | +$24.2M | 2.33% | 9 |
|
|
2014
Q2 | $278M | Buy |
9,885,268
+619,620
| +7% | +$17.7M | 2.19% | 11 |
|
|
2014
Q1 | $282M | Buy |
9,265,648
+476,276
| +5% | +$14.2M | 2.42% | 10 |
|
|
2013
Q4 | $255M | Buy |
8,789,372
+365,801
| +4% | +$10.6M | 2.33% | 7 |
|
|
2013
Q3 | $229M | Buy |
8,423,571
+42,751
| +0.5% | +$1.16M | 2.31% | 11 |
|
|
2013
Q2 | $223M | Buy |
+8,380,820
| New | +$232M | 2.4% | 8 |
|
Other funds holding PFE
VCM
VPM
Diamond Hill Capital Management's PFE Position: Q1 2026 in Review
Diamond Hill Capital Management reduced its Pfizer (PFE) stake by 35% in Q1 2026, selling an estimated $88.7M and leaving 6,108,570 shares worth $172M. The position accounts for 1.07% of the portfolio, ranked #34.
Diamond Hill Capital Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $580M in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Diamond Hill Capital Management held 6,108,570 shares of Pfizer worth $172M as of Q1 2026.
- Diamond Hill Capital Management sold 3,330,697 Pfizer shares in Q1 2026, an estimated $88.7M.
- Pfizer made up 1.07% of Diamond Hill Capital Management's portfolio in Q1 2026, its #34 holding.
- Diamond Hill Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Diamond Hill Capital Management's Pfizer position peaked at $580M in Q4 2021.
- 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Diamond Hill Capital Management's 13F filing for Q1 2026, filed 7 May 2026.